Open Nav

Peter Heifetz, PhD

President and CEO

OrPro Therapeutics Inc

Over 25 years senior R&D management and discovery/development experience with CSO and corp dev positions at venture-backed companies Rincon Pharma, GreenFuel, and ERA Biotech. Dr. Heifetz began his industry career at Ciba-Geigy Biotechnology and held positions of increasing responsibility with Novartis (NYSE:NVS) and the Novartis Research Foundation, then transitioned to the global life sciences company Syngenta (NYSE:SYT) after its spinout from Novartis. At Syngenta he led world-wide R&D for Syngenta Biopharma and was head of consumer health at the Syngenta Torrey Mesa Research Institute prior to joining Diversa Corp (NASDAQ:DVSA) as a Fellow. Dr. Heifetz received BS, MS and PhD degrees from Duke University in genetics and biochemical engineering, and earned a certificate in innovation management from the Kenan-Flagler School of Business at UNC-Chapel Hill. He is an inventor on over 100 issued patents/published applications and author of multiple scientific publications.

This speaker's sessions: